James Anderson
Rheumatology · Overland Park, KSNPI 1801892377
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,975 of the $75,322 with a category attached, or 77.0%. AbbVie accounts for 91.6% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $28,179 and has fallen 98.5% since, to $433 in 2025. Among rheumatology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 693 payments — averaging $108.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$69K
- Amgen$1K
- Johnson & Johnson$992
- Novartis$708
- Lilly USA, LLC$685
- GSK$651
- plus $2K from 25 others
What the payments were for
- Speaking & faculty fees$57,97577%
- Travel & lodging$5,0487%
- Food & beverage$12,17816%
- Education$1210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 298 | $69,030 |
| Amgen(2 entities) | 80 | $1,150 |
| Johnson & Johnson | 65 | $992 |
| Novartis | 45 | $708 |
| Lilly USA, LLC | 48 | $685 |
| GSK | 46 | $651 |
| Genentech USA, Inc. | 21 | $377 |
| AstraZeneca(2 entities) | 13 | $351 |
| Sobi, Inc | 12 | $287 |
| Boehringer Ingelheim | 10 | $195 |
| Sanofi | 10 | $146 |
| UCB, Inc. | 7 | $124 |
| Novo Nordisk | 6 | $109 |
| CSL Behring | 2 | $86 |
| E.r. Squibb & Sons, L.L.C. | 5 | $72 |
| Hospira, Inc. | 4 | $55 |
| Pfizer | 3 | $49 |
| Merck | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Aurinia Pharma U.S., Inc. | 1 | $21 |
| Organon | 3 | $20 |
| Mallinckrodt Hospital Products Inc. | 1 | $20 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Bristol Myers Squibb | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $17 |
| Pharming Healthcare, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Boston Scientific | 1 | $14 |
| Genentech, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $13 |
| Octapharma USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$75,322 in reported general payments places this provider in the 95th percentile of 49 rheumatology providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 43 | $342,529 |
| RinvoqUpadacitinib | 34 | $271,632 |
| Enbrel SureclickEtanercept | 15 | $111,420 |
| Enbrel MiniEtanercept | 12 | $94,543 |
| Xeljanz XrTofacitinib Citrate | 15 | $86,070 |
| Hydroxychloroquine Sulfate | 993 | $29,312 |
| MethotrexateMethotrexate Sodium | 490 | $8,331 |
| Mycophenolate Mofetil | 55 | $5,749 |
| SavellaMilnacipran Hcl | 11 | $5,454 |
| Doxycycline Hyclate | 173 | $4,429 |
| Leflunomide | 113 | $4,401 |
| Prednisone | 573 | $3,056 |
| Colchicine | 36 | $2,863 |
| Sulfasalazine | 136 | $2,811 |
| Celecoxib | 109 | $2,503 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRinvoq, Savella | $69,030 | $277,08645 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 49 rheumatology providers in Kansas.
Other rheumatology in Overland Park
- Stephen RuhlmanOverland Park$32K
- Arnold KatzOverland Park$25K
- Aruna BarathamOverland Park$23K
- Shirley WangOverland Park$19K
- Sarah VodopestOverland Park$4K
- Jonathan AmosOverland Park$4K
- Carrie MihordinOverland Park$4K
- Christopher KoenigOverland Park$391
- Shashank RadadiyaKansas City$74K
- Timothy ShaverWichita$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.